Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2132231A in metastatic cutaneous melanoma
NCT00896480Phase 2Completed
- Sponsor
- GSK
- Start
- May 2009
- Primary completion
- Nov 2014
- Modality
- Vaccines & Immunotherapeutics, Peptides, Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of astuprotimut-R in cutaneous melanoma (CM), sponsored by GSK. Started May 2009; status: completed.
02
Drugs
astuprotimut-R
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT00896480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00896480.